Abstract
Mechanisms of brain and retinal iron homeostasis have become subjects of increased interest after the discovery of elevated iron levels in brains of patients with Alzheimer's disease and retinas of patients with age-related macular degeneration. To determine whether the ferroxidase ceruloplasmin (Cp) and its homolog hephaestin (Heph) are important for retinal iron homeostasis, we studied retinas from mice deficient in Cp and/or Heph. In normal mice, Cp and Heph localize to Müller glia and retinal pigment epithelium, a blood–brain barrier. Mice deficient in both Cp and Heph, but not each individually, had a striking, age-dependent increase in retinal pigment epithelium and retinal iron. The iron storage protein ferritin was also increased in Cp–/–Heph–/Y retinas. After retinal iron levels had increased, Cp–/–Heph–/Y mice had age-dependent retinal pigment epithelium hypertrophy, hyperplasia and death, photoreceptor degeneration, and subretinal neovascularization, providing a model of some features of the human retinal diseases aceruloplasminemia and age-related macular degeneration. This pathology indicates that Cp and Heph are critical for CNS iron homeostasis and that loss of Cp and Heph in the mouse leads to age-dependent retinal neurodegeneration, providing a model that can be used to test the therapeutic efficacy of iron chelators and antiangiogenic agents.
Iron is an essential cofactor in heme and nonheme-containing enzymes, but ferrous iron (Fe2+) generates free radicals that can cause oxidative damage via the Fenton reaction. Homeostatic regulation of ferrous iron levels is critical for meeting physiologic demand while preventing the toxicity associated with iron overload.
Consistent with a need for precise regulation of retinal iron, iron overload can cause retinal degenerations. Iron retained in the eye as a foreign body or injected into the vitreous causes photoreceptor degeneration, demonstrating that iron overload is toxic to photoreceptors (1–3). A comparison of postmortem retinas from age-related macular degeneration (AMD) and normal donors documented increased iron within the retinal pigment epithelium (RPE) (4), a cellular monolayer forming the blood-retinal barrier and nourishing photoreceptors. These results suggest that iron overload may play a role in the pathogenesis of AMD, a retinal degeneration that is the most common cause of irreversible vision loss in the U.S.
Iron overload is also implicated in the retinal degeneration occurring in patients with the rare autosomal recessive disease aceruloplasminemia. These patients have pathologic accumulation of iron in liver, spleen, pancreas, retina, and basal ganglia by the fourth or fifth decade of life (5, 6). Five Japanese patients all had pigmentary retinopathy by their fifth decade (5–7). Although histopathology has not been published, one patient had retinal iron overload in unspecified cell types (6). One Caucasian patient with undetectable serum ceruloplasmin had drusen, yellowish white spots under the retina that constitute the defining clinical feature of AMD (J.L.D., unpublished results). Because this patient's drusen were first detected at age 46, an early onset of AMD, this finding further suggests a link between retinal iron overload and AMD.
Ceruloplasmin (Cp) is a multicopper ferroxidase produced by alternate splicing as either a membrane-linked (8) or secreted protein. The secreted form circulates in the blood but does not cross the blood–brain barrier (8). Thus, to function beyond the blood–retinal barrier, Cp must be expressed in the retina. Within the normal human and mouse retinas, Cp expression was detected in the inner nuclear layer (9, 10), with increased expression in the inner nuclear layer and ganglion cell layer after optic nerve crush (11) and an increase in Müller glia after photic injury (12).
Evidence suggests that Cp facilitates iron export from cells. By oxidizing ferrous to ferric iron, the only form that can be taken up by the serum transport protein, transferrin, Cp may establish an ion gradient favoring iron export. In vitro, Cp is necessary for iron export from brain astrocytes (13) and can facilitate iron export from macrophages (14). Further, Cp–/– mice have impaired liver iron efflux (15). Unlike humans with aceruloplasminemia, our Cp–/– mice do not manifest significant CNS iron overload or neuropathy even at 24 months. An independently generated Cp–/– mouse showed mild CNS iron overload, and cells from these mice had increased susceptibility to oxidative stress (16).
One potential explanation for the lack of severe CNS iron overload in Cp–/– mice is that hephaestin (Heph), another multicopper ferroxidase with 50% identity to Cp, may also facilitate iron export. Heph is naturally mutated in the sex-linked anemia (sla) mouse (17). Because Heph is a membrane-bound protein that mediates iron egress from intestinal enterocytes into the circulation (17), sla mice are anemic as a result of impaired intestinal iron absorption. The Heph mutation in the sla mouse is a deletion of two exons resulting in a predicted deletion of 194 aa. As a result, sla mice have significantly diminished Heph ferroxidase activity (18).
Before the present study, Heph had not to our knowledge been studied in the retina. To test the hypothesis that deficiency of both Cp and Heph would induce retinal iron overload and neurodegeneration, we generated mice harboring both our Cp knockout allele and the sex-linked Heph mutation from sla mice and studied male mice herein referred to as Cp–/–Heph–/Y mice. We find that combined deficiency of Cp and Heph results in retinal iron accumulation with secondary increases in several forms of the iron storage protein ferritin and, ultimately, retinal degeneration.
Methods
Generation of Mice and Fixation of Eyes. C57BL/6 mice with a targeted mutation in the Cp gene (Cp–/–) (15), C57BL/6 mice with the naturally occurring sla mutation in the Heph gene (designated herein as Heph–/Y, as Heph resides on the X chromosome), and mice generated by crossing both single knockout mice (Cp–/–Heph–/Y) were studied. Eyes were enucleated immediately after death and fixed overnight in 4% paraformaldehyde with or without 0.5% glutaraldehyde or in 10% formalin. In addition, WT C57BL/6 and BALB/c eyes were enucleated and lightly fixed in 4% paraformaldehyde for 2 h before use for immunohistochemistry. All procedures were approved by the Institutional Animal Care and Use Committee of the University of Pennsylvania. Human eyes were obtained from the National Disease Research Interchange through a protocol approved by the University of Pennsylvania Institutional Review Board. They were enucleated 3 h postmortem and kept on ice until retinas were dissected 24 h later and used for Western analysis.
Dissection of Murine RPE and Retinas for RT-PCR and Western Analysis. C57BL/6 mice were killed, and eyes were promptly enucleated. Anterior segments were removed, and retinas were completely dissected away from the underlying RPE. Retinas were then flash-frozen and stored at –80°C. RPE was enzymatically detached from the remaining posterior segment by incubation in 0.25% trypsin at 37°C, 5% CO2 for 20 min. Detached RPE was collected in an Eppendorf tube, pelleted, flash-frozen, and stored at –80°C.
RT-PCR. RNA was extracted from primary murine RPE and spontaneously immortalized human ARPE-19 cells (19) by using TRIzol (GIBCO/BRL) and used to generate first-strand cDNA with a T7-(dT)24-mer primer and the SuperScript II reverse transcriptase (GIBCO). Specific sequences were then amplified by PCR using a PTC-0200 thermocycler (MJ Research, Cambridge, MA).
Primers for rod opsin, RPE65, Cp (amplifying both the secreted and glycosylphosphatidylinositol-linked forms), and Heph were designed to span intron–exon boundaries within genomic DNA to amplify cDNA and minimize amplification of potentially contaminating genomic DNA. The murine opsin forward primer was 5′-TCTTCACAGTCAAGGAGGCG-3′, with a reverse primer of 5′-ACAGCGTGGTGAGCATACAG-3′. For murine RPE65, the designed forward primer was 5′-TTACGTGAGAATTGGGAAGAAG-3′, and the reverse primer was 5′-AGGATCTTTTGAACAGTCCATG-3′. The murine Cp forward primer was 5′ACAGTTGTTCCAACGTTACC-3′, whereas the reverse primer was 5′-ACTCCCCTGTGCTTGTATTG-3′. The human Cp forward primer was 5′-CCACAAGGCCCTACTCAATAC-3′, and the reverse primer was 5′-AACAGAAGGGCAAATTCCAG-3′. For murine Heph, the forward primer was 5′-CAAAGTTACAGGGCAGATGTGGTG-3′, and the reverse primer was 5′CCAGAGCAATGAGCAACAGAAGC-3′. The human Heph forward primer was 5′-TGGGAAACTCTATGCCAACCTTAG3′, and the reverse primer was 5′-ATGGACCTCCTATTGCGTCGTAGC-3′.
Western Analysis. Protein from normal human retinas, murine retinas, and cultured cell lines (ARPE-19 and rMC-1) was isolated and subjected to Western analysis as described in ref. 12 by using rabbit anti-Cp (DAKO; 1:1,000) or rabbit anti-Heph (Alpha Diagnostic, San Antonio, TX; 1:1,000) antibodies.
Histochemical Iron Detection. Paraffin sections (5 μm thick) prepared from whole globes were Perls' stained by incubation in 5% potassium ferrocyanide in 5% aqueous hydrochloric acid for 30 min at room temperature, yielding a Prussian blue reaction product. Sensitivity for iron detection was enhanced by subsequent incubation in 0.75 mg/ml 3,3′-diaminobenzidine (DAB) and 0.00075% H2O2 for 30 min at room temperature, yielding a brown reaction product. As the Perls' reaction product was found in pigmented RPE, sections were bleached by incubation overnight in 3% H2O2 before staining to improve visibility of Perls' signal. Sections were analyzed by light and fluorescence microscopy with a Nikon TE-300 microscope and a SpotRT Slider camera (Diagnostic Instruments, Sterling Heights, MI) with imagepro plus software, Version 4.1 (Media Cybernetics, Silver Spring, MD).
Quantitative Iron Detection. Retinas from WT, Cp–/–, Heph–/Y, and Cp–/–Heph–/Y mice were dissected from the underlying RPE/choroid/sclera. Iron in these tissues was measured by graphite furnace atomic absorption spectrophotometry (model 5100 AA, PerkinElmer) by using standard methods (20).
Electron Microscopy and Energy-Dispersive X-Ray Spectroscopy. Retinas (including RPE) fixed in 2% paraformaldeyhyde, 2% glutaraldehyde were postfixed in 1% osmium tetroxide, 0.1 M sodium cacodylate buffer. Specimens were dehydrated and embedded in Epon (Ted Pella, Inc., Redding, CA). Ultrathin sections were cut, stained with uranyl acetate, and examined with a JEOL 1010 transmission electron microscope. Semithin 1- to 3-μm sections were stained with toluidine blue or methylene blue/azure II and analyzed by light microscopy as described above.
Energy-dispersive x-ray spectroscopy was performed with scanning mode, and spectra were collected with a Kevex 8000 energy-dispersive x-ray spectrometer (Thermo Electron, Pea-body, MA) installed on an H-600 electron microscope (Hitachi, Pleasanton, CA), as described in ref. 21 on 200-nm-thick sections without any secondary stain.
Immunohistochemistry. Fixed globes were rinsed in PBS and prepared as eyecups, which were treated with 0.1% sodium borohydride (if fixed in glutaraldehyde), cryoprotected in 30% sucrose, and embedded in Tissue-Tek OCT (Sakura Finetek, Torrance, CA).
Immunohistochemistry was performed on cryosections 10 μm thick as published in ref. 22. Primary antibodies were rabbit anti-Heph (1:500; J. Gitlin, Washington University, St. Louis), mouse anti-cellular retinaldehyde binding protein (CRALBP) (1:250; J. Saari, University of Washington, Seattle), rabbit anti-light ferritin (F17), and heavy ferritin (Y17) [both 1:2,500; P. Santambrogio (Instituto di Ricovero e Cura a Carattere Scientifico, Milan) and P. Arosio (University of Brescia, Brescia, Italy)]. Control sections were treated identically but with omission of primary antibody. Specificity of ferritin immunoreactivity was confirmed by preincubation of antibody with a 5 M excess of antigenic or unrelated protein. Sections were analyzed by fluorescence microscopy using identical exposure parameters across genotypes as described above.
Results
Cp and Heph Are Expressed in RPE. To investigate normal expression of Cp and Heph, RT-PCR analysis was performed on RPE dissected from C57BL/6 mice. In two different experiments, one from a single 6-month-old C57BL/6 mouse (Fig. 1A) and another from three mice 3, 5, and 7 months old, respectively (data not shown), both Cp and Heph mRNAs were detected in RPE. To confirm RPE expression of Cp and Heph, RT-PCR analysis was also performed on the human ARPE-19 cell line (19). As with the dissected mouse RPE, ARPE cells expressed Cp and Heph. The purity of isolated RPE was demonstrated by amplification of RPE65, an RPE-specific gene, but not opsin, a retina-specific gene.
Cp and Heph Proteins Are Present in Müller Glia and RPE. Consistent with the RT-PCR results, Western analysis detected both Cp and Heph proteins in ARPE-19 cells. Both proteins were also present in mouse and human retina and rMC-1 cells, a rat Müller glial cell line, with Cp protein migrating at ≈130 kDa and Heph at ≈150 kDa (Fig. 1B). Cp from human tissue (purified plasma Cp and ARPE-19) migrated slightly slower than from rodent tissue (mouse retina and rMC-1).
We and others demonstrated by immunohistochemistry that Cp protein is present diffusely throughout the murine retina, particularly in Müller cells whose Cp levels increase after retinal stress (11, 12). Similarly, Heph localizes to Müller cells as identified by colabeling with anti-Heph and CRALBP, a Müller cell and RPE marker (Fig. 1G). Heph was present in Müller cell bodies within the inner nuclear layer and in Müller cell processes extending radially through the retina. Highest levels of Heph were found in the Müller endfeet adjacent to the internal limiting membrane at the inner surface of the retina.
Weak Heph immunofluorescence was present in RPE cells. This modest RPE immunofluorescence was greater than that of the 2° antibody-only control (Fig. 1C). Even though the control was intentionally imaged with a ×10 longer exposure time than the other panels in Fig. 1, no signal was present. The faint Heph signal in the RPE (Fig. 1D) is consistent with the RT-PCR (Fig. 1 A) and Western data (Fig. 1B), indicating that Heph mRNA and protein are present in the RPE.
At age 5–6 months, Cp–/–Heph–/Y retinas have increased iron, with highest levels in the RPE and photoreceptor outer segments. Because Cp and Heph mRNAs and proteins are present in retina and RPE, retinas deficient in these ferroxidases (n = 5 for each genotype) were analyzed by the Perls' stain for iron to determine whether their deficiency would result in iron accumulation. Iron in all normal, Cp–/–, and Heph–/Y retinas studied (up to 9 months old) was below the limits of detection by Perls' stain (Fig. 2 A and B) even with DAB enhancement (Fig. 2F). In contrast, all Cp–/–Heph–/Y retinas >5 months old (n = 5) had a striking granular Perls' stain in the RPE (Fig. 2 C and D); DAB enhancement further detected regional photoreceptor outer segment iron in Cp–/–Heph–/Y retinas (Fig. 2E).
At the ultrastructural level, the RPE of 5- to 6-month-old Cp–/–Heph–/Y but not WT or single knockout eyes contained electron-dense vesicles visible without Perls' staining. These single-membrane enclosed vesicles were most likely lysosomes or endosomes, sometimes fused with melanosomes (Fig. 2G). Energy-dispersive x-ray spectroscopy showed that the electrondense particles had high iron peaks, at least four times higher than in melanosomes or other cytoplasmic locations in the WT RPE or outside of the vesicles in the Cp–/–Heph–/Y RPE.
To quantify iron accumulation, dissected sclera/choroid/RPE and dissected neural retinas (without RPE) from 7-month-old mice were analyzed by atomic absorption spectrophotometry. There was little difference between WT, Cp–/–, and Heph–/Y tissues, whereas the Cp–/–Heph–/Y tissue had significant increases in iron. When Cp–/–Heph–/Y tissues (n = 3) were compared to non-Cp–/–Heph–/Y tissues (n = 4), sclera/choroid/RPE had a 4.2-fold increase in Cp–/–Heph–/Y compared to non-Cp–/–Heph–/Y tissue (mean ± SEM, expressed in μg of iron per g of tissue: 194.2 ± 34.3 vs. 48.3 ± 11.1, P < 0.04). Cp–/–Heph–/Y retinas had a 3.6-fold increase in iron compared to non-Cp–/–Heph–/Y retinas (19.1 ± 3.4 vs. 5.2 ± 1.2, P < 0.04). This RPE and photoreceptor iron accumulation appears to be age-dependent, as no iron was detectable in a 4-week-old Cp–/–Heph–/Y retina by DAB-enhanced Perls' stain (data not shown).
Levels of Ferritins Are Increased in Cp–/–Heph–/Y Retinas. Levels of the cytosolic iron storage protein ferritin are controlled by intracellular iron levels; through the iron regulatory proteins IRP1 and IRP2, increased iron leads to increased cytosolic ferritin mRNA translation, leading to increased ferritin protein levels (23). Ferritin multimers are composed of heavy (H) and light (L) chains. To determine whether increased iron in 5- to 6-month-old Cp–/–Heph–/Y retinas is accompanied by increased ferritin, retinas (n = 4 from each genotype) were immunolabeled with anti-H-ferritin and anti-L-ferritin (Fig. 3). H- and L-ferritin immunoreactivity was much stronger in the Cp–/–Heph–/Y retinas than in Cp–/–, Heph–/Y (data not shown), or WT, consistent with the increased retinal iron detected by atomic absorption spectrophotometry. Both H- and L-ferritin were present among all genotypes in bipolar cell synaptic terminals in the inner plexiform layer. Additionally, H-ferritin immunoreactivity (Fig. 3 A–C) across all genotypes was strongest in photoreceptors, including their inner segments and axons in the outer part of the outer plexiform layer, whereas L-ferritin (Fig. 3 D–F) was localized to the inner aspect of the outer plexiform layer, the bipolar synaptic terminals, and RPE.
Cp–/–Heph–/Y Mice Surviving to 6–9 Months Exhibit Retinal Degeneration. Retinas from Cp–/–Heph–/Y mice surviving to age 6–9 months (n = 3) all had severe pathologic abnormalities. At the gross level, there were focal areas of hypopigmentation in the midperipheral retina, the largest spanning approximately one-third of the distance from optic nerve to the anterior edge of the retina (Fig. 4). Histology described below suggests that decreased concentration of RPE pigment caused by RPE hypertrophy and RPE death as well as underlying choroidal thinning account for the hypopigmentation.
The RPE cells in affected Cp–/–Heph–/Y but not age-matched WT retinas were massively hypertrophic in up to half the eye in confluent stretches spanning up to ≈75% of the length of the retina in a given section (Fig. 5C) and in the remainder of the eye in focal patches comprising a few hypertrophic cells (Fig. 5B). Electron microscopy analysis of these hypertrophic Cp–/–Heph–/Y RPE demonstrated numerous phagosomes and lysosomes containing partially digested photoreceptor outer segment membranes (Fig. 5G). Electron-dense vesicles were also observed in these affected 6- to 9-month-old Cp–/–Heph–/Y RPE, similar to those observed in the histologically normal, younger Cp–/–Heph–/Y RPE.
In addition to these areas of hypertrophic RPE with a normal appearing neural retina, within each eye there were also a few focal areas of extensive RPE hyperplasia and necrosis (Fig. 5 D and E) accompanied by local photoreceptor loss and subretinal neovascularization. Focal areas of subretinal deposits were also observed at the ultrastructural level. Clusters of these deposits spanned regions ranging from 50 to 500 μm and contained banded structures with a periodicity of 110 nm (Fig. 5H), similar to the wide-spaced collagen observed in basal laminar deposits in AMD retinas.
Discussion
Cp and Heph ferroxidases are believed to facilitate iron export from cells by oxidizing ferrous to ferric iron, the only form that can be taken up by the serum transport protein transferrin. Although Cp is up-regulated after stress in multiple tissues, including retina (11, 12), and although Cp is necessary for iron export from brain astrocytes in vitro (13), the role of Heph in the CNS and its functional relationship to Cp had not been characterized.
We demonstrate that Cp and Heph serve essential functions in retinal iron regulation. In the normal mouse, both ferroxidases are present in the RPE and retina. In the retinas of Cp–/–Heph–/Y mice, Perls' stain detected increased iron in outer segments of Cp–/–Heph–/Y photoreceptors by age 5–6 months, and atomic absorption spectrophotometry demonstrated increased retinal iron compared with non-Cp–/–Heph–/Y retinas. In the RPE, deficiency of both ferroxidases resulted in massive iron accumulation detectable even with the unenhanced Perls' stain and quantitatively confirmed by atomic absorption spectrophotometry. At age 6–9 months, some Cp–/–Heph–/Y mice developed retinal degeneration and neovascularization, emphasizing the importance of proper iron metabolism for retinal health.
Only mice with deficiency of both Cp and Heph developed retinal iron overload and degeneration. One potential mechanistic explanation for the iron overload is that Cp and Heph, which we show are both expressed in Muller glia and RPE cells, may facilitate iron export from the plasma membrane of these cells. Alternatively, they may mediate iron export from different intracellular compartments, with combined deficiency resulting in significant iron overload. Future studies with subcellular immunolocalization should shed light on this issue.
Age-Dependent Iron Overload in Cp–/–Heph–/Y Mice. The striking iron overload in the Cp–/–Heph–/Y mice occurs despite Heph deficiency-induced impairment of intestinal iron uptake, which causes low serum iron levels and anemia (17). At 5–6 months, Cp–/–Heph–/Y RPE contained iron-laden vesicles. Iron is normally taken into lysosomes of the RPE by endocytosis of transferrin-bound iron (24) or phagocytosis of iron-laden shed outer segments (25). These lysosomes fuse with melanosomes in RPE (26), potentially explaining the presence of fused ironladen vesicle/melanosomes in the Cp–/–Heph–/Y RPE.
Elevation of iron levels in Cp–/–Heph–/Y retinas resulted in increased levels of the cytosolic iron storage protein ferritin. Increased L-ferritin was observed in the Cp–/–Heph–/Y RPE, consistent with the Perls' label, but H-ferritin was not detectable in Cp–/–Heph–/Y RPE. Differential expression of these ferritin subunits is not unusual (27); liver, for example, expresses primarily L-ferritin, whereas heart expresses primarily H-ferritin (28).
Mechanistic and Structural Similarities Between Cp–/–Heph–/Y Retinas and Human Retinal Degeneration. Although histopathology of human retinal degeneration in aceruloplasminemia has not been described, clinical examination of an aceruloplasminemic Caucasian shows early-onset drusen, and fluorescein angiography of a Japanese aceruloplasminemic patient suggests RPE degeneration just peripheral to the macula, the central part of the retina. The histology of the 6- to 9-month-old Cp–/–Heph–/Y mouse retina may shed light on mechanisms of RPE degeneration and drusen formation in aceruloplasminemia. Like the murine Cp–/–Heph–/Y RPE, the RPE in human aceruloplasminemia is likely to be iron-overloaded, accumulate lysosomes, and eventually die. Unlike human aceruloplasminemia and Cp–/–Heph–/Y mice, retinas from Cp–/– mice do not exhibit RPE degeneration. This discrepancy could be explained by a very slow RPE iron accumulation caused by the absence of Cp in both mouse and human, too slow to cause RPE degeneration in the short lifespan of a mouse.
The subretinal neovascularization in Cp–/–Heph–/Y retinas has not been reported in patients with aceruloplasminemia, but does occur in other human retinal degenerations. AMD is thought to result from primary RPE death leading to secondary photoreceptor death, as appears to be the case in Cp–/–Heph–/Y retinas, and the progression of AMD to its wet form results in subretinal neovascularization, also seen in Cp–/–Heph–/Y eyes. Subretinal neovascularization in AMD most often originates from the choroid, with occasional contributions from the retinal circulation; the source of subretinal neovascularization in Cp–/–Heph–/Y eyes awaits further investigation. Other similarities between AMD and the Cp–/–Heph–/Y mouse are the presence of sub-RPE widespaced collagen (Fig. 5), a component of drusen, RPE lysosomal inclusions and death, and elevated levels of RPE iron (4). Despite the histologic similarities between the Cp–/–Heph–/Y mouse and AMD, the Cp–/–Heph–/Y mouse is not an exact phenocopy of AMD, as it lacks clinically observable drusen, and AMD retinas do not have such extensive RPE hypertrophy. Further, whereas several pieces of evidence suggest that iron overload may contribute to AMD [elevated iron levels in postmortem AMD retinas (4), early-onset drusen in an aceruloplasminemic patient (J.L.D., unpublished data), and some histologic features of AMD in Cp–/–Heph–/Y mice], further work is needed to test the role of iron overload in AMD. Mice with defects in macrophage recruitment develop sub-RPE deposits and choroidal neovascularization (29). It is possible that the combination of increased production of oxidized molecules, most likely a cause of retinal degeneration in the Cp–/–Heph–/Y mouse, and decreased clearance of such materials by macrophages can lead to AMD.
Implications for the CNS. Disordered iron metabolism has been implicated in both common and rare neurodegenerations. Elevated iron levels have been detected in Alzheimer's- and Parkinson's-affected brains and AMD-affected retinas (4, 30). The possibility that iron chelation may be therapeutic in such patients is supported by experiments in which iron chelation by either transgenic expression of the iron-binding protein ferritin or oral administration of the bioavailable metal chelator clioquinol reduced the severity of neurodegeneration in a mouse model of Parkinson's disease (31). Our Cp–/–Heph–/Y mice with iron overload-induced retinal degeneration provide an opportunity to test the efficacy of iron chelators and antioxidants for neuroprotection. Further, because Cp–/–Heph–/Y mice have limited viability as they approach 6–9 months of age, limiting the number of mice that live long enough to develop retinal degeneration, an RPE-specific conditional Heph knockout will facilitate investigation into the frequency and extent of pathology and other studies of age-dependent retinal degeneration. In summary, these data demonstrate that Cp and Heph are mediators of iron metabolism in a CNS site, the retina, such that deficiency of both yields a massive iron accumulation and corresponding RPE/retinal pathology.
Acknowledgments
We thank Robert Wong, Carrie Hegedus, Neelima Shah, Raymond Meade, Qian-Chun Yu, Melanie Minda, and John Tomaszewski for advice and assistance. This work was supported by a Research to Prevent Blindness (Career Development Award to J.L.D. and an unrestricted grant), the International Retina Research Foundation, National Institutes of Health/National Eye Institute Grants EY015240 and EY00417, National Institute of Diabetes and Digestive and Kidney Diseases Grants DK02464 and DK58086, the Steinbach Foundation, and the F. M. Kirby Foundation.
Abbreviations: Cp, ceruloplasmin; Heph, hephaestin; AMD, age-related macular degeneration; RPE, retinal pigment epithelium; CRALBP, cellular retinaldehyde binding protein; DAB, 3,3'-diaminobenzidine.
References
- 1.Doly, M., Bonhomme, B. & Vennat, J. C. (1986) Ophthalmic Res. 18, 21–27. [DOI] [PubMed] [Google Scholar]
- 2.Vergara, O., Ogden, T. & Ryan, S. (1989) Exp. Eye Res. 49, 1115–1126. [DOI] [PubMed] [Google Scholar]
- 3.Tawara, A. (1986) Invest. Ophthalmol. Visual Sci. 27, 226–236. [PubMed] [Google Scholar]
- 4.Hahn, P., Milam, A. H. & Dunaief, J. L. (2003) Arch. Ophthalmol. 121, 1099–1105. [DOI] [PubMed] [Google Scholar]
- 5.Miyajima, H., Nishimura, Y., Mizoguchi, K., Sakamoto, M., Shimizu, T. & Honda, N. (1987) Neurology 37, 761–767. [DOI] [PubMed] [Google Scholar]
- 6.Morita, H., Ikeda, S., Yamamoto, K., Morita, S., Yoshida, K., Nomoto, S., Kato, M. & Yanagisawa, N. (1995) Ann. Neurol. 37, 646–656. [DOI] [PubMed] [Google Scholar]
- 7.Yamaguchi, K., Takahashi, S., Kawanami, T., Kato, T. & Sasaki, H. (1998) Ophthalmologica 212, 11–14. [DOI] [PubMed] [Google Scholar]
- 8.Patel, B. N. & David, S. (1997) J. Biol. Chem. 272, 20185–20190. [DOI] [PubMed] [Google Scholar]
- 9.Klomp, L. W. & Gitlin, J. D. (1996) Hum. Mol. Genet. 5, 1989–1996. [DOI] [PubMed] [Google Scholar]
- 10.Klomp, L. W., Farhangrazi, Z. S., Dugan, L. L. & Gitlin, J. D. (1996) J. Clin. Invest. 98, 207–215. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Levin, L. A. & Geszvain, K. M. (1998) Invest. Ophthalmol. Visual Sci. 39, 157–163. [PubMed] [Google Scholar]
- 12.Chen, L., Dentchev, T., Wong, R., Hahn, P., Wen, R., Bennett, J. & Dunaief, J. L. (2003) Mol. Vis. 9, 151–158. [PubMed] [Google Scholar]
- 13.Jeong, S. Y. & David, S. (2003) J. Biol. Chem. 278, 27144–27148. [DOI] [PubMed] [Google Scholar]
- 14.Sarkar, J., Seshadri, V., Tripoulas, N. A., Ketterer, M. E. & Fox, P. L. (2003) J. Biol. Chem. 278, 44018–44024. [DOI] [PubMed] [Google Scholar]
- 15.Harris, Z. L., Durley, A. P., Man, T. K. & Gitlin, J. D. (1999) Proc. Natl. Acad. Sci. USA 96, 10812–10817. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Patel, B. N., Dunn, R. J., Jeong, S. Y., Zhu, Q., Julien, J. P. & David, S. (2002) J. Neurosci. 22, 6578–6586. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Vulpe, C. D., Kuo, Y. M., Murphy, T. L., Cowley, L., Askwith, C., Libina, N., Gitschier, J. & Anderson, G. J. (1999) Nat. Genet. 21, 195–199. [DOI] [PubMed] [Google Scholar]
- 18.Chen, H., Attieh, Z. K., Su, T., Syed, B. A., Gao, H., Alaeddine, R. M., Fox, T. C., Usta, J., Naylor, C. E., Evans, R. W., et al. (2004) Blood, in press. [DOI] [PubMed]
- 19.Dunn, K. C., Aotaki-Keen, A. E., Putkey, F. R. & Hjelmeland, L. M. (1996) Exp. Eye Res. 62, 155–169. [DOI] [PubMed] [Google Scholar]
- 20.Erikson, K. M., Pinero, D. J., Connor, J. R. & Beard, J. L. (1997) J. Nutr. 127, 2030–2038. [DOI] [PubMed] [Google Scholar]
- 21.Rawson, A. J., Patton, G. W., Hofmann, S., Pietra, G. G. & Johns, L. (1993) Ecotoxicol. Environ. Saf. 25, 41–47. [DOI] [PubMed] [Google Scholar]
- 22.Dunaief, J. L., Dentchev, T., Ying, G. S. & Milam, A. H. (2002) Arch. Ophthalmol. 120, 1435–1442. [DOI] [PubMed] [Google Scholar]
- 23.Rouault, T. & Klausner, R. (1997) Curr. Top. Cell. Regul. 35, 1–19. [DOI] [PubMed] [Google Scholar]
- 24.Hunt, R. C. & Davis, A. A. (1992) J. Cell. Physiol. 152, 102–110. [DOI] [PubMed] [Google Scholar]
- 25.Yefimova, M. G., Jeanny, J. C., Keller, N., Sergeant, C., Guillonneau, X., Beaumont, C. & Courtois, Y. (2002) Invest. Ophthalmol. Visual Sci. 43, 537–545. [PubMed] [Google Scholar]
- 26.Schraermeyer, U., Peters, S., Thumann, G., Kociok, N. & Heimann, K. (1999) Exp. Eye Res. 68, 237–245. [DOI] [PubMed] [Google Scholar]
- 27.Han, J., Day, J. R., Connor, J. R. & Beard, J. L. (2002) J. Nutr. 132, 2769–2774. [DOI] [PubMed] [Google Scholar]
- 28.Aisen, P., Enns, C. & Wessling-Resnick, M. (2001) Int. J. Biochem. Cell Biol. 33, 940–959. [DOI] [PubMed] [Google Scholar]
- 29.Ambati, J., Anand, A., Fernandez, S., Sakurai, E., Lynn, B. C., Kuziel, W. A., Rollins, B. J. & Ambati, B. K. (2003) Nat. Med. 9, 1390–1397. [DOI] [PubMed] [Google Scholar]
- 30.Perry, G., Sayre, L. M., Atwood, C. S., Castellani, R. J., Cash, A. D., Rottkamp, C. A. & Smith, M. A. (2002) CNS Drugs 16, 339–352. [DOI] [PubMed] [Google Scholar]
- 31.Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., Viswanath, V., Jacobs, R., Yang, L., Beal, M. F., et al. (2003) Neuron 37, 899–909. [DOI] [PubMed] [Google Scholar]